All News Baudax Bio, Inc.

Equities

Market Closed - OTC Markets Other stock markets 02:31:14 2024-07-08 pm EDT			5-day change	1st Jan Change
0.0043 ^USD	+65.38%		-42.67%	-80.45%

Jun. 17	First Motion for Exclusivity Period Extension Filed by Baudax Bio, Inc.	CI
Feb. 22	Baudax Bio, Inc. Filed for Bankruptcy	CI

First Motion for Exclusivity Period Extension Filed by Baudax Bio, Inc.	Jun. 17	CI
Baudax Bio, Inc. Filed for Bankruptcy	Feb. 22	CI
Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20	CI
Baudax Bio, Inc.(OTCPK:BXRX) dropped from S&P TMI Index	Nov. 20	CI
Baudax Bio, Inc.(OTCPK:BXRX) dropped from NASDAQ Composite Index	Nov. 16	CI
Baudax Bio : Change in Certifying Accountants - Form 8-K	23-10-25	PU
Baudax Bio Announces Corporate Update	23-10-18	AQ
Baudax Bio, Inc. to Initiate TI-168 Clinical Development	23-10-18	CI
Sector Update: Health Care Stocks Advancing in Late Afternoon Trading	23-10-06	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	23-10-06	MT
Baudax Bio Appoints Natalie McAndrew as Interim Finance Chief	23-10-06	MT
Baudax Bio : Corporate Overview	23-10-06	PU
Baudax Bio, Inc. Announces Board Changes	23-10-06	CI
Baudax Bio, Inc. Announces Chief Financial Officer Changes	23-10-06	CI
Wall Street Set to Open Higher; Personal Consumption Inflation Data Lower Than Expected	23-09-29	MT
Top Premarket Decliners	23-09-29	MT
Baudax Bio, Inc. Announces Orphan Drug Designation Granted by U.S. Fda for Ti-168 for the Treatment of Hemophilia A with Inhibitors	23-09-29	CI
Sector Update: Health Care Stocks Rising in Late Afternoon Trading	23-09-28	MT
Sector Update: Health Care	23-09-28	MT
Top Midday Gainers	23-09-28	MT

No results for this search